Yunkang Group (HKSE:02325) Days Sales Outstanding : 760.64 (As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Yunkang Group Days Sales Outstanding?

Yunkang Group's average Accounts Receivable for the six months ended in Dec. 2023 was HK$1,890.2 Mil. Yunkang Group's Revenue for the six months ended in Dec. 2023 was HK$453.5 Mil. Hence, Yunkang Group's Days Sales Outstanding for the six months ended in Dec. 2023 was 760.64.

The historical rank and industry rank for Yunkang Group's Days Sales Outstanding or its related term are showing as below:

HKSE:02325' s Days Sales Outstanding Range Over the Past 10 Years
Min: 110.83 Med: 140.19 Max: 818.22
Current: 810.59

During the past 6 years, Yunkang Group's highest Days Sales Outstanding was 818.22. The lowest was 110.83. And the median was 140.19.

HKSE:02325's Days Sales Outstanding is ranked worse than
97.7% of 217 companies
in the Medical Diagnostics & Research industry
Industry Median: 69.88 vs HKSE:02325: 810.59

Yunkang Group's Days Sales Outstanding increased from Dec. 2022 (156.17) to Dec. 2023 (760.64).

Warning Sign:

If a company's sales outstanding increases, it means it has difficulty collecting payments from its customers.

Yunkang Group Days Sales Outstanding Historical Data

The historical data trend for Yunkang Group's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Yunkang Group Days Sales Outstanding Chart

Yunkang Group Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

133.49

110.83

139.22

162.14

818.22

Yunkang Group Semi-Annual Data
	Dec18	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Days Sales Outstanding	Get a 7-Day Free Trial				160.45	160.28	156.17	846.87	760.64

Competitive Comparison of Yunkang Group's Days Sales Outstanding

For the Diagnostics & Research subindustry, Yunkang Group's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Yunkang Group's Days Sales Outstanding Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Yunkang Group's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Yunkang Group's Days Sales Outstanding falls into.

Yunkang Group Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Yunkang Group's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (2716.034	+	1655.75)	/	2 )	/	975.104	*	365
=	2185.892					/	975.104	*	365
=	818.22

Yunkang Group's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jun. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (2124.705	+	1655.75)	/	2 )	/	453.519	*	365 / 2
=	1890.2275					/	453.519	*	365 / 2
=	760.64

Yunkang Group (HKSE:02325) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Yunkang Group Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Yunkang Group's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Yunkang Group (HKSE:02325) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Yunkang Group Ltd (HKSE:02325) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 6 Lizhishan Road, Science City, Huangpu District, Guangzhou, CHN

Website

http://www.yunkanghealth.com

Yunkang Group Ltd is a medical operation service provider in China. The company has three major business lines namely covering diagnostic testing services for medical consortia, diagnostic outsourcing services, and non-medical institutions.

Executives

Huizekx Limited	2201 Interest of corporation controlled by you
Yk Development Limited	2101 Beneficial owner
Zhang Yong	2201 Interest of corporation controlled by you
Shanghai Pudong Development Bank Co., Ltd	2201 Interest of corporation controlled by you
Zhou Xinyu
Guang Zhou Da An Ji Yin Gu Fen You Xian Gong Si	2201 Interest of corporation controlled by you
Da An Guo Ji Ji Tuan You Xian Gong Si	2101 Beneficial owner
Guang Zhou Shi Da An Ji Yin Ke Ji You Xian Gong Si	2201 Interest of corporation controlled by you
Jin Jun Ying Limited	2201 Interest of corporation controlled by you
Mouduans Limited	2201 Interest of corporation controlled by you
Source Capital Rw Limited	2201 Interest of corporation controlled by you
Tongfuzc Limited	2201 Interest of corporation controlled by you
Wjjr Investment Limited	2201 Interest of corporation controlled by you

Yunkang Group (HKSE:02325) Headlines

No Headlines